DK0784974T3 - Fremstilling af xanthinderivater i fast dispersion - Google Patents
Fremstilling af xanthinderivater i fast dispersionInfo
- Publication number
- DK0784974T3 DK0784974T3 DK96916342T DK96916342T DK0784974T3 DK 0784974 T3 DK0784974 T3 DK 0784974T3 DK 96916342 T DK96916342 T DK 96916342T DK 96916342 T DK96916342 T DK 96916342T DK 0784974 T3 DK0784974 T3 DK 0784974T3
- Authority
- DK
- Denmark
- Prior art keywords
- solid dispersion
- preparation
- xanthine derivatives
- hxdrogen
- hxdroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19005895 | 1995-07-26 | ||
PCT/JP1996/001555 WO1997004782A1 (fr) | 1995-07-26 | 1996-06-07 | Dispersion solide ou preparation a dispersion solide de derives xanthine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0784974T3 true DK0784974T3 (da) | 2003-09-01 |
Family
ID=16251650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96916342T DK0784974T3 (da) | 1995-07-26 | 1996-06-07 | Fremstilling af xanthinderivater i fast dispersion |
Country Status (9)
Country | Link |
---|---|
US (1) | US6254889B1 (da) |
EP (1) | EP0784974B1 (da) |
JP (1) | JP3938938B2 (da) |
AT (1) | ATE240734T1 (da) |
DE (1) | DE69628276T2 (da) |
DK (1) | DK0784974T3 (da) |
ES (1) | ES2199289T3 (da) |
PT (1) | PT784974E (da) |
WO (1) | WO1997004782A1 (da) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2287971T3 (es) | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
ES2307482T3 (es) * | 1999-02-10 | 2008-12-01 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas. |
AU2331801A (en) * | 1999-12-23 | 2001-07-09 | F.H. Faulding & Co. Limited | Improved pharmaceutical compositions for poorly soluble drugs |
AU784340B2 (en) | 1999-12-23 | 2006-03-16 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
AR028253A1 (es) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | Inhibidores de la glucogeno fosforilasa |
AU2256702A (en) * | 2000-12-01 | 2002-06-11 | Kyowa Hakko Kogyo Kk | Composition improved in solubility or oral absorbability |
US20030082231A1 (en) * | 2001-02-02 | 2003-05-01 | Cheryl Kos | Coating for orally administered compositions |
JP4310605B2 (ja) * | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
CA2450957A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
JP2005523262A (ja) * | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物 |
JP4482925B2 (ja) * | 2002-02-22 | 2010-06-16 | 味の素株式会社 | アミノ酸類粉末及びその製造方法 |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
EP1932529A1 (en) | 2003-04-25 | 2008-06-18 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
US20060293312A1 (en) * | 2003-04-25 | 2006-12-28 | Howard Dittrich | Method of improved diuresis in individuals with impaired renal function |
KR20060004959A (ko) * | 2003-04-25 | 2006-01-16 | 노바카르디아, 인코포레이션 | 신장 기능 저하를 갖는 개별 대상자의 이뇨 작용 개선 방법 |
WO2004099207A1 (ja) * | 2003-05-09 | 2004-11-18 | Kyowa Hakko Kogyo Co. Ltd. | 微細結晶 |
JP2007501218A (ja) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 |
EP1755594A1 (en) * | 2004-04-16 | 2007-02-28 | Novacardia, Inc. | Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
US20080312587A1 (en) * | 2005-06-10 | 2008-12-18 | Gruenethal Gmbh | System for the Oral Administration of Solids to Persons Suffering from Dementia |
EP1961422A1 (en) * | 2005-12-14 | 2008-08-27 | Kyowa Hakko Kogyo Co., Ltd. | Easily absorbed oral preparation containing xanthine derivative |
JP2007308480A (ja) * | 2006-04-20 | 2007-11-29 | Shin Etsu Chem Co Ltd | 腸溶性固体分散体を含んでなる固形製剤 |
EP2035009A1 (en) * | 2006-06-16 | 2009-03-18 | Novacardia, Inc. | Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
US20080242684A1 (en) * | 2007-03-29 | 2008-10-02 | Howard Dittrich | Methods of administration of adenosine a1 receptor antagonists |
US20090197900A1 (en) * | 2007-03-29 | 2009-08-06 | Howard Dittrich | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
GB0708258D0 (en) * | 2007-04-27 | 2007-06-06 | Katholleke Universiteit Leuven | New anti-viral nulceoside analogs |
US8703204B2 (en) | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
WO2008135828A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
WO2008149230A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
WO2008149192A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
SI2200588T1 (sl) | 2007-09-25 | 2019-08-30 | Solubest Ltd. | Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo |
US9233078B2 (en) | 2007-12-06 | 2016-01-12 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
US9724362B2 (en) | 2007-12-06 | 2017-08-08 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
EP2262768A4 (en) * | 2008-03-11 | 2011-03-23 | Reddys Lab Ltd Dr | PREPARATION OF LENALIDOMIDE |
CN104507480A (zh) | 2012-06-21 | 2015-04-08 | 梅恩医药国际有限公司 | 伊曲康唑组合物和剂型及其使用方法 |
TWI615157B (zh) * | 2013-02-06 | 2018-02-21 | 大塚製藥股份有限公司 | 包括不定形西洛他唑的固體分散劑 |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
EP3340982B1 (en) | 2015-08-26 | 2021-12-15 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
EP3939591A1 (en) | 2016-06-27 | 2022-01-19 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
TWI780270B (zh) | 2017-11-28 | 2022-10-11 | 靜岡縣公立大學法人 | 固體分散體 |
EP3841086A4 (en) | 2018-08-20 | 2022-07-27 | Achillion Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D |
WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976071A (en) * | 1974-01-07 | 1976-08-24 | Dynatech Corporation | Methods of improving control of release rates and products useful in same |
US5286489A (en) * | 1985-08-26 | 1994-02-15 | The Procter & Gamble Company | Taste masking compositions |
WO1988000051A1 (en) * | 1986-06-24 | 1988-01-14 | Racz Istvan | Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability |
JP2521461B2 (ja) | 1987-03-10 | 1996-08-07 | エスエス製薬株式会社 | 持続性錠剤 |
ES2077023T3 (es) * | 1989-03-10 | 1995-11-16 | Yamanouchi Pharma Co Ltd | Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada. |
US5290782A (en) | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
JPH06102662B2 (ja) * | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
DK0580860T4 (da) * | 1991-04-16 | 2005-03-21 | Nippon Shinyaku Co Ltd | Fremgangsmåde til fremstilling af en fast dispersion |
-
1996
- 1996-06-07 US US08/809,651 patent/US6254889B1/en not_active Expired - Fee Related
- 1996-06-07 JP JP50744297A patent/JP3938938B2/ja not_active Expired - Fee Related
- 1996-06-07 DE DE69628276T patent/DE69628276T2/de not_active Expired - Fee Related
- 1996-06-07 ES ES96916342T patent/ES2199289T3/es not_active Expired - Lifetime
- 1996-06-07 EP EP96916342A patent/EP0784974B1/en not_active Expired - Lifetime
- 1996-06-07 AT AT96916342T patent/ATE240734T1/de not_active IP Right Cessation
- 1996-06-07 PT PT96916342T patent/PT784974E/pt unknown
- 1996-06-07 DK DK96916342T patent/DK0784974T3/da active
- 1996-06-07 WO PCT/JP1996/001555 patent/WO1997004782A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2199289T3 (es) | 2004-02-16 |
EP0784974A4 (en) | 2000-09-27 |
DE69628276D1 (de) | 2003-06-26 |
WO1997004782A1 (fr) | 1997-02-13 |
ATE240734T1 (de) | 2003-06-15 |
US6254889B1 (en) | 2001-07-03 |
JP3938938B2 (ja) | 2007-06-27 |
EP0784974A1 (en) | 1997-07-23 |
EP0784974B1 (en) | 2003-05-21 |
DE69628276T2 (de) | 2004-04-08 |
PT784974E (pt) | 2003-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0784974T3 (da) | Fremstilling af xanthinderivater i fast dispersion | |
DK0778277T3 (da) | Substituerede heterocycliske derivater som CRF antagonister | |
DE69027235T2 (de) | Xanthinderivate | |
DE69533277D1 (de) | Dc-89 derivat | |
AU9281198A (en) | Benzofuran derivatives | |
ATE176470T1 (de) | Xanthinderivate | |
ATE204576T1 (de) | Methotrexat-derivate | |
DK0958821T3 (da) | Fedtemulsion, der indeholder xanthinderivat | |
ES2123873T3 (es) | Pirrolocarbazol. | |
ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
DE69326479T2 (de) | Methotrexat-derivate | |
DE69231244T2 (de) | Pyrazolothiazolopyrimidin-derivate | |
ATE268769T1 (de) | Pyrimidinderivate mit antitumor-wirkung |